These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33833224)

  • 1. Subgenual cingulate resting regional cerebral blood flow in premenstrual dysphoric disorder: differential regulation by ovarian steroids and preliminary evidence for an association with expression of ESC/E(Z) complex genes.
    Wei SM; Baller EB; Martinez PE; Goff AC; Li HJ; Kohn PD; Kippenhan JS; Soldin SJ; Rubinow DR; Goldman D; Schmidt PJ; Berman KF
    Transl Psychiatry; 2021 Apr; 11(1):206. PubMed ID: 33833224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder.
    Dubey N; Hoffman JF; Schuebel K; Yuan Q; Martinez PE; Nieman LK; Rubinow DR; Schmidt PJ; Goldman D
    Mol Psychiatry; 2017 Aug; 22(8):1172-1184. PubMed ID: 28044059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.
    Nguyen TV; Reuter JM; Gaikwad NW; Rotroff DM; Kucera HR; Motsinger-Reif A; Smith CP; Nieman LK; Rubinow DR; Kaddurah-Daouk R; Schmidt PJ
    Transl Psychiatry; 2017 Aug; 7(8):e1193. PubMed ID: 28786978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
    Schmidt PJ; Martinez PE; Nieman LK; Koziol DE; Thompson KD; Schenkel L; Wakim PG; Rubinow DR
    Am J Psychiatry; 2017 Oct; 174(10):980-989. PubMed ID: 28427285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study.
    Baller EB; Wei SM; Kohn PD; Rubinow DR; Alarcón G; Schmidt PJ; Berman KF
    Am J Psychiatry; 2013 Mar; 170(3):305-14. PubMed ID: 23361612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic intersection of BDNF Val66Met genotype with premenstrual dysphoric disorder transcriptome in a cross-species model of estradiol add-back.
    Marrocco J; Einhorn NR; Petty GH; Li H; Dubey N; Hoffman J; Berman KF; Goldman D; Lee FS; Schmidt PJ; McEwen BS
    Mol Psychiatry; 2020 Mar; 25(3):572-583. PubMed ID: 30356121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered estradiol-dependent cellular Ca
    Li HJ; Goff A; Rudzinskas SA; Jung Y; Dubey N; Hoffman J; Hipolito D; Mazzu M; Rubinow DR; Schmidt PJ; Goldman D
    Mol Psychiatry; 2021 Nov; 26(11):6963-6974. PubMed ID: 34035477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli.
    Gingnell M; Bannbers E; Wikström J; Fredrikson M; Sundström-Poromaa I
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1474-83. PubMed ID: 24001875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain reactivity during aggressive response in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator.
    Kaltsouni E; Fisher PM; Dubol M; Hustad S; Lanzenberger R; Frokjaer VG; Wikström J; Comasco E; Sundström-Poromaa I
    Neuropsychopharmacology; 2021 Jul; 46(8):1460-1467. PubMed ID: 33927343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotrophic hormone and reinforcement sensitivity systems in women with premenstrual dysphoric disorder.
    Ko CH; Long CY; Yen CF; Chen CS; Wang PW; Yen JY
    Psychiatry Clin Neurosci; 2014 Nov; 68(11):785-94. PubMed ID: 24735107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women.
    Berman KF; Schmidt PJ; Rubinow DR; Danaceau MA; Van Horn JD; Esposito G; Ostrem JL; Weinberger DR
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8836-41. PubMed ID: 9238064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
    [No Abstract]   [Full Text] [Related]  

  • 14. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome.
    Tiranini L; Nappi RE
    Fac Rev; 2022; 11():11. PubMed ID: 35574174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trait-related changes in brain network topology in premenstrual dysphoric disorder.
    Dan R; Reuveni I; Canetti L; Weinstock M; Segman R; Goelman G; Bonne O
    Horm Behav; 2020 Aug; 124():104782. PubMed ID: 32470339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition.
    Bannbers E; Gingnell M; Engman J; Morell A; Comasco E; Kask K; Garavan H; Wikström J; Sundström Poromaa I
    J Affect Disord; 2012 Dec; 142(1-3):347-50. PubMed ID: 22840469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptive processing in women with premenstrual dysphoric disorder (PMDD): the role of menstrual phase and sex hormones.
    Bartley EJ; Palit S; Kuhn BL; Kerr KL; Terry EL; DelVentura JL; Rhudy JL
    Clin J Pain; 2015 Apr; 31(4):304-14. PubMed ID: 24810651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone and plasma metabolites in women with and in those without premenstrual dysphoric disorder.
    Di Florio A; Alexander D; Schmidt PJ; Rubinow DR
    Depress Anxiety; 2018 Dec; 35(12):1168-1177. PubMed ID: 30184299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premenstrual dysphoric disorder is associated with the longer length from clitoris to urethra.
    Li Z; Xu MJ; Jin Y; Zhu BG
    BMC Womens Health; 2021 Jul; 21(1):266. PubMed ID: 34225734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.